Crossref
Hypoalbuminemia as a relapse risk factor after high dose chemotherapy and autologous stem cell transplantation in patients with Hodgkin’s lymphoma
OncoReview · 2019
DOI: 10.24292/01.or.101218 ↗Kurz gefasst
Fachartikel in der Zeitschrift OncoReview, 2019. Verfasst von Paweł Koźlik und 5 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Koźlik, P., Długosz-Danecka, M., Pacholczak, R., Bryk, A., Krawczyk, A., & Jurczak, W. (2019). Hypoalbuminemia as a relapse risk factor after high dose chemotherapy and autologous stem cell transplantation in patients with Hodgkin’s lymphoma. OncoReview. https://doi.org/10.24292/01.or.101218
Vancouver
Koźlik P, Długosz-Danecka M, Pacholczak R, Bryk A, Krawczyk A, Jurczak W. Hypoalbuminemia as a relapse risk factor after high dose chemotherapy and autologous stem cell transplantation in patients with Hodgkin’s lymphoma. OncoReview. 2019. doi:10.24292/01.or.101218
BibTeX
@article{Kolik2019,
author = {Koźlik, Paweł and Długosz-Danecka, Monika and Pacholczak, Renata and Bryk, Agata and Krawczyk, Agata and Jurczak, Wojciech},
title = {Hypoalbuminemia as a relapse risk factor after high dose chemotherapy and autologous stem cell transplantation in patients with Hodgkin’s lymphoma},
journal = {OncoReview},
year = {2019},
doi = {10.24292/01.or.101218}
}
EUVIMED